What are the long-term side effects of losartan
Pro Research Analysisby 
Searched over 200M research papers
Long-Term Side Effects of Losartan
Introduction to Losartan and Its Uses
Losartan is a widely used angiotensin II receptor antagonist primarily prescribed for managing hypertension and heart failure. It works by blocking the angiotensin II type 1 receptor, which helps in lowering blood pressure and reducing strain on the heart. While it is effective in treating these conditions, understanding its long-term side effects is crucial for both patients and healthcare providers.
Hematological Effects: Decrease in Hemoglobin
One of the significant long-term side effects of losartan is a reduction in hemoglobin levels. In a study involving renal transplant recipients, a notable decrease in mean hemoglobin concentration was observed over a period of 14 months of losartan therapy (from 13.5±1.74 g/dl to 12.2±2.19 g/dl) . This suggests that patients on long-term losartan therapy should have their hemoglobin levels monitored regularly to manage potential anemia.
Renal Function: Acute and Long-Term Changes
Losartan has complex effects on renal function. Initially, it may cause an acute fall in glomerular filtration rate (GFR), which can be concerning. However, this initial decline is often followed by a slower rate of long-term renal function deterioration. This pattern was observed in the RENAAL trial, where patients experienced a significant initial drop in estimated GFR (eGFR) during the first three months of treatment, but a slower decline in eGFR over the long term . This indicates that while losartan may initially stress the kidneys, it could potentially offer protective benefits against long-term renal function loss.
Cardiovascular and Hemodynamic Effects
Losartan is effective in reducing systemic vascular resistance and blood pressure, which are beneficial for heart failure patients. Long-term administration of losartan has shown sustained hemodynamic benefits, including reduced systemic vascular resistance and pulmonary capillary wedge pressure, and improved cardiac index . These effects contribute to its efficacy in managing heart failure, although continuous monitoring is necessary to ensure these benefits outweigh any potential risks.
Impact on Proteinuria
In renal transplant patients, losartan has demonstrated a significant reduction in proteinuria, which is a positive outcome for kidney health. Over a treatment period of up to 28 months, patients showed a marked decrease in proteinuria levels (from 1.0±0.87 g/l to 0.4±0.83 g/l) . This reduction in proteinuria without adversely affecting graft function highlights losartan's potential renal protective effects.
Tolerability and Common Adverse Events
Losartan is generally well-tolerated, with a safety profile comparable to placebo in many studies. Common adverse events include headache, upper respiratory tract infections, dizziness, and fatigue, with dizziness being slightly more frequent in losartan-treated groups . These side effects are typically mild and manageable, making losartan a viable option for long-term therapy in hypertensive patients.
Conclusion
Losartan is an effective antihypertensive and heart failure medication with a generally favorable long-term safety profile. Key long-term side effects include a reduction in hemoglobin levels and an initial decline in renal function, which may be followed by a slower rate of renal deterioration. Its benefits in reducing proteinuria and maintaining hemodynamic stability make it a valuable treatment option, though regular monitoring is essential to manage and mitigate potential adverse effects.
Sources and full results
Most relevant research papers on this topic